nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenobarbital—GABRA2—conduct disorder	0.879	1	CbGaD
Methylphenobarbital—CHRNA4—autonomic nervous system—conduct disorder	0.00749	0.44	CbGeAlD
Methylphenobarbital—GABRA6—GABA A receptor activation—GABRA2—conduct disorder	0.00551	0.0565	CbGpPWpGaD
Methylphenobarbital—GABRA4—GABA A receptor activation—GABRA2—conduct disorder	0.00544	0.0557	CbGpPWpGaD
Methylphenobarbital—GABRA5—GABA A receptor activation—GABRA2—conduct disorder	0.00484	0.0495	CbGpPWpGaD
Methylphenobarbital—GABRA3—GABA A receptor activation—GABRA2—conduct disorder	0.00475	0.0486	CbGpPWpGaD
Methylphenobarbital—GABRA1—GABA A receptor activation—GABRA2—conduct disorder	0.00398	0.0408	CbGpPWpGaD
Methylphenobarbital—GABRA6—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00337	0.0346	CbGpPWpGaD
Methylphenobarbital—GABRA4—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00333	0.0341	CbGpPWpGaD
Methylphenobarbital—Hexobarbital—GABRA2—conduct disorder	0.0031	0.541	CrCbGaD
Methylphenobarbital—GABRA5—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00296	0.0303	CbGpPWpGaD
Methylphenobarbital—GABRA3—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00291	0.0298	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.00261	0.0268	CbGpPWpGaD
Methylphenobarbital—GABRA1—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00244	0.025	CbGpPWpGaD
Methylphenobarbital—GRIA2—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.00192	0.0197	CbGpPWpGaD
Methylphenobarbital—Primidone—GABRA2—conduct disorder	0.0018	0.314	CrCbGaD
Methylphenobarbital—GABRA6—GABA receptor activation—GABRA2—conduct disorder	0.00179	0.0183	CbGpPWpGaD
Methylphenobarbital—GABRA4—GABA receptor activation—GABRA2—conduct disorder	0.00177	0.0181	CbGpPWpGaD
Methylphenobarbital—GABRA5—GABA receptor activation—GABRA2—conduct disorder	0.00157	0.0161	CbGpPWpGaD
Methylphenobarbital—GABRA3—GABA receptor activation—GABRA2—conduct disorder	0.00154	0.0158	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00129	0.0133	CbGpPWpGaD
Methylphenobarbital—GABRA1—GABA receptor activation—GABRA2—conduct disorder	0.00129	0.0132	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00118	0.0121	CbGpPWpGaD
Methylphenobarbital—GABRA6—Orphan transporters—GABRA2—conduct disorder	0.00104	0.0107	CbGpPWpGaD
Methylphenobarbital—GABRA4—Orphan transporters—GABRA2—conduct disorder	0.00103	0.0106	CbGpPWpGaD
Methylphenobarbital—GRIA2—brain—conduct disorder	0.000997	0.0586	CbGeAlD
Methylphenobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00099	0.0101	CbGpPWpGaD
Methylphenobarbital—GRIK2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000973	0.00997	CbGpPWpGaD
Methylphenobarbital—GABRA6—brain—conduct disorder	0.000963	0.0566	CbGeAlD
Methylphenobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00096	0.00983	CbGpPWpGaD
Methylphenobarbital—GABRA5—brain—conduct disorder	0.000934	0.0549	CbGeAlD
Methylphenobarbital—GABRA5—Orphan transporters—GABRA2—conduct disorder	0.000916	0.00938	CbGpPWpGaD
Methylphenobarbital—CHRFAM7A—brain—conduct disorder	0.000908	0.0534	CbGeAlD
Methylphenobarbital—GRIK2—brain—conduct disorder	0.000901	0.053	CbGeAlD
Methylphenobarbital—GABRA3—Orphan transporters—GABRA2—conduct disorder	0.0009	0.00921	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000885	0.00907	CbGpPWpGaD
Methylphenobarbital—GABRA3—brain—conduct disorder	0.00087	0.0511	CbGeAlD
Methylphenobarbital—GABRA4—brain—conduct disorder	0.000848	0.0498	CbGeAlD
Methylphenobarbital—Pethidine—SLC6A4—conduct disorder	0.000834	0.145	CrCbGaD
Methylphenobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000823	0.00843	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000813	0.00833	CbGpPWpGaD
Methylphenobarbital—GABRA1—Orphan transporters—GABRA2—conduct disorder	0.000754	0.00772	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neuronal System—GABRA2—conduct disorder	0.000746	0.00764	CbGpPWpGaD
Methylphenobarbital—GRIA2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000744	0.00762	CbGpPWpGaD
Methylphenobarbital—CHRNA7—brain—conduct disorder	0.000734	0.0431	CbGeAlD
Methylphenobarbital—GABRA6—Ion channel transport—GABRA2—conduct disorder	0.000733	0.0075	CbGpPWpGaD
Methylphenobarbital—CHRNA4—brain—conduct disorder	0.000724	0.0426	CbGeAlD
Methylphenobarbital—GABRA4—Ion channel transport—GABRA2—conduct disorder	0.000723	0.00741	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000722	0.0074	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000722	0.00739	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000709	0.00726	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000686	0.00703	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—GABRA2—conduct disorder	0.000678	0.00695	CbGpPWpGaD
Methylphenobarbital—GABRA2—brain—conduct disorder	0.000648	0.0381	CbGeAlD
Methylphenobarbital—GABRA5—Ion channel transport—GABRA2—conduct disorder	0.000643	0.00658	CbGpPWpGaD
Methylphenobarbital—GABRA3—Ion channel transport—GABRA2—conduct disorder	0.000631	0.00646	CbGpPWpGaD
Methylphenobarbital—GABRA1—brain—conduct disorder	0.000626	0.0368	CbGeAlD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000619	0.00634	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000611	0.00626	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000594	0.00609	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—GABRA2—conduct disorder	0.00057	0.00584	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000559	0.00573	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—GABRA2—conduct disorder	0.000553	0.00566	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000543	0.00556	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000533	0.00546	CbGpPWpGaD
Methylphenobarbital—GABRA1—Ion channel transport—GABRA2—conduct disorder	0.000529	0.00542	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000516	0.00529	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.000514	0.00527	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—GABRA2—conduct disorder	0.000474	0.00486	CbGpPWpGaD
Methylphenobarbital—GRIK2—Transmission across Chemical Synapses—COMT—conduct disorder	0.000468	0.0048	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—GABRA2—conduct disorder	0.000468	0.0048	CbGpPWpGaD
Methylphenobarbital—GRIK2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000465	0.00476	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000447	0.00458	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Transmission across Chemical Synapses—COMT—conduct disorder	0.000426	0.00436	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000423	0.00433	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000421	0.00431	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000421	0.00431	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—GABRA2—conduct disorder	0.000416	0.00426	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—GABRA2—conduct disorder	0.000409	0.00418	CbGpPWpGaD
Methylphenobarbital—CYP2B6—brain—conduct disorder	0.000369	0.0217	CbGeAlD
Methylphenobarbital—GRIK2—Neuronal System—COMT—conduct disorder	0.000359	0.00368	CbGpPWpGaD
Methylphenobarbital—GRIA2—Transmission across Chemical Synapses—COMT—conduct disorder	0.000358	0.00367	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neuronal System—MAOA—conduct disorder	0.000356	0.00365	CbGpPWpGaD
Methylphenobarbital—GRIA2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000356	0.00364	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—COMT—conduct disorder	0.000347	0.00356	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000346	0.00355	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000345	0.00353	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000343	0.00351	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—GABRA2—conduct disorder	0.000342	0.00351	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—COMT—conduct disorder	0.000326	0.00334	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—MAOA—conduct disorder	0.000324	0.00332	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000308	0.00316	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—COMT—conduct disorder	0.000298	0.00305	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000296	0.00303	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—COMT—conduct disorder	0.000294	0.00301	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000292	0.00299	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—COMT—conduct disorder	0.000274	0.00281	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—MAOA—conduct disorder	0.000272	0.00279	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—COMT—conduct disorder	0.000266	0.00273	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—MAOA—conduct disorder	0.000264	0.00271	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—COMT—conduct disorder	0.000261	0.00268	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00026	0.00267	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000259	0.00266	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—COMT—conduct disorder	0.000257	0.00263	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000255	0.00261	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000255	0.00261	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—COMT—conduct disorder	0.000252	0.00258	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000252	0.00258	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00025	0.00256	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000233	0.00239	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—COMT—conduct disorder	0.000228	0.00234	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—MAOA—conduct disorder	0.000227	0.00232	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—COMT—conduct disorder	0.000225	0.00231	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—MAOA—conduct disorder	0.000224	0.00229	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000224	0.00229	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000223	0.00228	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00022	0.00225	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—COMT—conduct disorder	0.000215	0.0022	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000214	0.00219	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000212	0.00218	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—COMT—conduct disorder	0.0002	0.00205	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—MAOA—conduct disorder	0.000199	0.00204	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—COMT—conduct disorder	0.000197	0.00201	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—MAOA—conduct disorder	0.000195	0.002	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—COMT—conduct disorder	0.000193	0.00198	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—MAOA—conduct disorder	0.000192	0.00197	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000184	0.00189	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000182	0.00186	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—COMT—conduct disorder	0.000165	0.00169	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—COMT—conduct disorder	0.000165	0.00169	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.000164	0.00168	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—MAOA—conduct disorder	0.000164	0.00168	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.000163	0.00167	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—COMT—conduct disorder	0.000125	0.00128	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.000124	0.00127	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.000123	0.00126	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000113	0.00115	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000106	0.00109	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CGA—conduct disorder	6.25e-05	0.00064	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CGA—conduct disorder	4.72e-05	0.000484	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—COMT—conduct disorder	2.82e-05	0.000289	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—MAOA—conduct disorder	2.8e-05	0.000287	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—COMT—conduct disorder	2.13e-05	0.000218	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—MAOA—conduct disorder	2.12e-05	0.000217	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	2.05e-05	0.00021	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—EP300—conduct disorder	1.21e-05	0.000124	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—EP300—conduct disorder	9.14e-06	9.37e-05	CbGpPWpGaD
